Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 18, 2022

Effect of SGLT2 Inhibitors in Patients With Heart Failure

The Lancet

 

Additional Info

The Lancet
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Lancet 2022 Sep 03;400(10354)757-767, M Vaduganathan, KF Docherty, BL Claggett, PS Jhund, RA de Boer, AF Hernandez, SE Inzucchi, MN Kosiborod, CSP Lam, F Martinez, SJ Shah, AS Desai, JJV McMurray, SD Solomon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading